As the calendar turned to 2022, the Global Competent Cells Industry found itself on the verge of a transformative era, projecting a substantial valuation of US$2.1 billion by the end of the year. This remarkable achievement is fueled by an impressive Compound Annual Growth Rate (CAGR) of 11.1% anticipated from 2022 to 2032, signifying the …